Cite
MLA Citation
J. Wollenhaupt et al.. “THU0185 Tofacitinib, An Oral JAK Inhibitor, in The Treatment of Rheumatoid Arthritis: Safety and Clinical and Radiographic Efficacy in Open-Label, Long-Term Extension Studies over 7 Years.” Annals of the rheumatic diseases, vol. 75, n.d., p. 252. http://access.bl.uk/ark:/81055/vdc_100135132543.0x000057